Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care

01/08/2022

Fabio Ynoe de Moraes, Gustavo Nader Marta,Gunita Mitera, Daniel Neves Forte, Rodrigo Nascimento Pinheiro , Nivaldo F Vieira , Rafael Gadia , Maira Caleffi , Patricia Chiappin Kauer , Luciana Holtz de Camargo Barros , Clarissa Mathias , Karina Gondim Moutinho da Conceicao Vasconcelos , Christopher Booth , Gustavo Dos Santos Fernandes

Full link: https://pubmed.ncbi.nlm.nih.gov/35941378/

Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care

Send us a message

Cura Project

Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care

Related Posts

In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”

Moderately hypofractionated post-operative radiation therapy for breast cancer: Preferences amongst radiation oncologists from countries in Latin America and the Caribbean

TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018

Subgroup analysis of Brazilian participants of a medical leadership competencies instrument: a cross-sectional survey study of the Latin American Cooperative Oncology Group (LACOG) and the Academy of Leadership Sciences Switzerland (ALSS)